92 related articles for article (PubMed ID: 1302351)
1. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
Idzior-Waluś B
Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351
[TBL] [Abstract][Full Text] [Related]
2. [Examination of cortisol and insulin levels in serum of patients with primary hyperlipoproteinemia and phenotype IIa and IIb during lovastatin treatment].
Idzior-Waluś B
Przegl Lek; 1992; 49(11):365-8. PubMed ID: 1306568
[TBL] [Abstract][Full Text] [Related]
3. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].
Idzior-Waluś B
Przegl Lek; 1992; 49(10):327-33. PubMed ID: 1308286
[TBL] [Abstract][Full Text] [Related]
4. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
Sznajd J; Idzior-Waluś B; Korzus G; Zabiński J; Hebda A; Markiewicz M
Przegl Lek; 1990; 47(10):711-4. PubMed ID: 2089450
[TBL] [Abstract][Full Text] [Related]
5. [Changes in the level of certain hemostatic factors during treatment with lovastatin in patients with primary hyperlipoproteinemia and phenotype IIa and IIb].
Idzior-Waluś B
Przegl Lek; 1992; 49(10):334-9. PubMed ID: 1308287
[TBL] [Abstract][Full Text] [Related]
6. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
[TBL] [Abstract][Full Text] [Related]
7. [The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia].
Iurenev AP; Zhukova IM; Lediashova GA; Kiseleva OA; Pomerantsev EV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):71-4. PubMed ID: 2604892
[TBL] [Abstract][Full Text] [Related]
8. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
[TBL] [Abstract][Full Text] [Related]
9. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.
McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M
Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
Farnier M; Bonnefous F; Debbas N; Irvine A
Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
[TBL] [Abstract][Full Text] [Related]
12. [Modification of serum lipids, lipoproteins and apoproteins AI and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine].
Noseda G; Suvà F; Fragiacomo C
Schweiz Med Wochenschr; 1985 Jul; 115(30):1064-70. PubMed ID: 4035328
[TBL] [Abstract][Full Text] [Related]
13. [The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia].
Zhukova IM; Iurenev AP; Pomerantsev EV; Martynov AA; Shabalkin BV; Titov VN; Shimbaeva NA; Kotkina AA; Bochkova EI; Lediashova GA
Ter Arkh; 1990; 62(8):130-3. PubMed ID: 2274859
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
15. The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level.
Branchi A; Rovellini A; Fiorenza AM; Maraffi F; Gandini R; Sommariva D
Int J Clin Pharmacol Ther; 1996 Sep; 34(9):384-9. PubMed ID: 8880287
[TBL] [Abstract][Full Text] [Related]
16. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
[TBL] [Abstract][Full Text] [Related]
18. [Lovastatin in the treatment of primary hypercholesterolemia].
Broda G; Rywik S; Chotkowska E; Bednarek M; Kuzmińska A; Polakowska M
Kardiol Pol; 1991; 35(8):84-9. PubMed ID: 1942761
[TBL] [Abstract][Full Text] [Related]
19. Management of primary mixed hyperlipidemia with lovastatin.
Vega GL; Grundy SM
Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864
[TBL] [Abstract][Full Text] [Related]
20. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G
Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
